| Schedule of debt |
Debt as of March 31, 2018 and December
31, 2017, was comprised of the following:
| |
|
2018 |
|
|
2017 |
|
| |
|
|
|
|
| Convertible notes payable, interest at 8% per annum, unpaid principal and interest maturing 3 years from note date between August 2018 and October 2019, convertible into common stock at the option of the lenders at a rate of $0.70 per share; one convertible note for $250,000 has a personal guarantee of an officer of the Company. |
|
|
1,605,000 |
|
|
|
1,605,000 |
|
| |
|
|
|
|
|
|
|
|
| Debt discount |
|
|
(5,200 |
) |
|
|
(7,200 |
) |
| |
|
|
|
|
|
|
|
|
| Secured short term note payable dated September 13, 2017 with principal and interest due 60 days from issuance.
The note requires a one-time fee in the amount of $15,000 to compensate for the first two weeks of the term and each week thereafter
(weeks 3-8) a fee of $1,500 shall be due and owing accruing on the first day of the week. The total one time fee paid was $24,000.
A fee of 100,000 shares of restricted common stock shall be issued as a penalty for each month or prorated for any two-week portion
of any month the note is outstanding past the original maturity date for months 3 through 6, and a fee of 200,000 shares of restricted
common stock shall be issued to lender for each month or prorated for each two-week portion of any month the note is outstanding
past the original maturity date beginning in month 7 until paid in full. The note is secured by the future sale of CoronaLux™
units and a personal guarantee of an officer of the Company. The penalty period for shares to be issued has been reached and for
the three months ended March 31, 2018 and the year ended December 31, 2017, the Company recorded 300,000 shares and 150,000 shares
of its common stock as issuable under the terms of this agreement, respectively. The shares were valued at $138,900 and $100,000
for the three months ended March 31, 2018 and the year ended December 31, 2017, respectively, and were recorded as interest expense
in the applicable period. Additional shares will be issued by the Company under the terms of the agreement (see Note 19). |
|
|
300,000 |
|
|
|
300,000 |
|
| |
|
|
|
|
|
|
|
|
| Secured short term note payable dated October 13, 2017 with principal and interest due 60 days from issuance.
The note requires a one-time fee in the amount of $4,000 to compensate for the first two weeks of the term and each week thereafter
(weeks 3-8) a fee of $400 shall be due and owing accruing on the first day of the week. The total one time fee paid was $6,400.
A fee of 40,000 shares of restricted common stock shall be issued as a penalty for each month or prorated for any two-week portion
of any month the note is outstanding past the original maturity date for months 3 through 6, and a fee of 80,000 shares of restricted
common stock shall be issued to lender for each month or prorated for each two-week portion of any month the note is outstanding
past the original maturity date beginning in month 7 until paid in full. The note is secured by the future sale of CoronaLux™
units and a personal guarantee of an officer of the Company. The penalty period for shares to be issued
has been reached and for the three months ended March 31, 2018 and the year ended December 31, 2017, the Company recorded 120,000
shares and 40,000 shares of its common stock, respectively, as issuable under the terms of this agreement. The shares were valued
at $55,500 and $30,000 for the three months ended March 31, 2018 and the year ended December 31, 2017, respectively, and were recorded
as interest expense in the applicable period. Additional shares will be issued by the Company under the terms of the agreement
(see Note 19). |
|
|
100,000 |
|
|
|
100,000 |
|
| Secured short term note payable dated November 6, 2017 with principal and interest due 60 days from issuance.
The note requires a one-time fee in the amount of $5,000 to compensate for the first two weeks of the term and each week thereafter
(weeks 3-8) a fee of $400 shall be due and owing accruing on the first day of the week. The total one time fee paid was $7,400.
A fee of 50,000 shares of restricted common stock shall be issued as a penalty for each month or prorated for any two-week portion
of any month the note is outstanding past the original maturity date for months 3 through 6, and a fee of 100,000 shares of restricted
common stock shall be issued to lender for each month or prorated for each two-week portion of any month the note is outstanding
past the original maturity date beginning in month 7 until paid in full. The note is secured by the future sale of CoronaLux™
units and a personal guarantee of an officer of the Company. The penalty period for shares to be issued had not been reached as
of December 31, 2017 but was reached as of March 31, 2018. During the three months ended March 31, 2018, the Company recorded 150,000
shares of its common stock as issuable under the terms of this agreement. The shares were valued at $64,500 recorded as interest
expense. Additional shares will be issued by the Company under the terms of the agreement (see Note 19). |
|
|
125,000 |
|
|
|
125,000 |
|
| |
|
|
|
|
|
|
|
|
| Note payable dated November 20, 2017, interest at 30% per annum, principal and accrued interest due on or before February 28, 2018. Unpaid interest at March 31, 2018 is approximately $7,600. The note is unsecured. During 2018, a verbal agreement was made to allow month-to-month extension of the due date as long as interest payments were made monthly. |
|
|
300,000 |
|
|
|
300,000 |
|
| |
|
|
|
|
|
|
|
|
| Secured short term note payable dated January 26, 2018 with principal and interest due 60 days from issuance.
The note requires a one-time fee in the amount of $12,500 to compensate for the first two weeks of the term and each week thereafter
(weeks 3-8) a fee of $1,250 shall be due and owing accruing on the first day of the week. The total one time fee paid was $17,500.
A fee of 100,000 shares of restricted common stock shall be issued as a penalty for each month or prorated for any two-week portion
of any month the note is outstanding past the original maturity date for months 3 through 6, and a fee of 200,000 shares of restricted
common stock shall be issued to lender for each month or prorated for each two-week portion of any month the note is outstanding
past the original maturity date beginning in month 7 until paid in full. The note is secured by the future sale of CoronaLux™
units and a personal guarantee of an officer of the Company. The penalty period for shares to be issued has been reached and the
Company will issue shares under the terms of the agreement (see Note 19). |
|
|
250,000 |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
| Note payable dated February 27, 2018 due on or before May 31, 2018 requiring a one-time fee in the amount of $25,000 to be paid as interest along with the principal in the due date. In the event the note and interest are not paid on or before June 1, 2018, a fee of $5,000 shall be due and owing accruing on the first day of each month commencing June 1, 2018. The note is secured by all of the proceeds from the sale of SEM’s BioActive Media paid to or received by SEM or MV. |
|
|
100,000 |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
| Note payable dated October 13, 2015, interest at 8% per annum, payable in 60 monthly installments of principal and interest $4,562, due October 1, 2020. Secured by real estate and other assets of SEM and guaranteed by SEER and MV. |
|
|
126,800 |
|
|
|
137,900 |
|
| |
|
|
|
|
|
|
|
|
| Note payable insurance premium financing, interest at 4.56% per annum, payable in 10 installments of $37,833, due November 1, 2018. |
|
|
258,400 |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
Capital lease obligations, secured by certain assets, maturing through Nov 2020
|
|
|
95,500 |
|
|
|
109,900 |
|
| Total notes payable and capital lease obligations |
|
|
3,255,500 |
|
|
|
2,670,600 |
|
| |
|
|
|
|
|
|
|
|
| Less: current portion |
|
|
(2,769,600 |
) |
|
|
(2,166,300 |
) |
| Notes payable and capital lease obligations, long-term, including debt discount |
|
$ |
485,900 |
|
|
$ |
504,300 |
|
|